FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

AAGILENT TECHNOLOGIES, INC.

Inspect →

AAAlcoa Corp

Inspect →

AAAUGoldman Sachs Physical Gold ETF

Inspect →

AACAres Acquisition Corp III

Inspect →

AACGATA Creativity Global

Inspect →

AACIArmada Acquisition Corp. III

Inspect →

AACOAbony Acquisition Corp. I

Inspect →

AACPApogee Acquisition Corp

Inspect →

AADXApplied Aerospace & Defense, Inc.

Inspect →

AAGHAmerica Great Health

Inspect →

AALAmerican Airlines Group Inc.

Inspect →

AAMEATLANTIC AMERICAN CORP

Inspect →

03 / FINANCIAL CHANGES

Tarsus Pharmaceuticals, Inc. TARS

Biological Products, (No Diagnostic Substances) · SIC 2836

Full analysis →

Latest standalone quarter

Period ending 2026-09-30

Filed: 2026-11-03 · Retrieved: 2026-11-05

Compared with the same period of the prior year, ending 2025-09-30.

Revenue194.57

USD million

Change year over year: +75.87 · +63.9%

Net income-668.33

USD million

Change year over year: -655.75

Operating cash flow-6.00

USD million

Change year over year: -24.26

Total liabilities401.47

USD million

Change year over year: +201.99

Total assets505.50

USD million

Change year over year: -29.06

Liabilities / assets: 79.4% · Change: +42.1 percentage points

Open original filing ↗

Latest annual report

Period ending 2025-12-31

Filed: 2026-02-23 · Retrieved: 2026-11-05

Compared with the same period of the prior year, ending 2024-12-31.

Revenue451.36

USD million

Change year over year: +268.41 · +146.7%

Net income-66.42

USD million

Change year over year: +49.14

Operating cash flow-12.45

USD million

Change year over year: +70.58

Total liabilities218.73

USD million

Change year over year: +66.28

Total assets562.16

USD million

Change year over year: +185.17

Liabilities / assets: 38.9% · Change: -1.5 percentage points

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

Company	Period ending	Revenue (USD million)	Net margin	Operating cash margin
LENZ ↗	2025-12-31	19.09	-430.3%	-362.4%
RLAY ↗	2025-12-31	15.36	-1,800.6%	-1,533.4%
DNLI ↗	2025-12-31	0.00	—	—
VIR ↗	2025-12-31	68.56	-638.9%	-571.5%
DTIL ↗	2025-12-31	34.26	-133.4%	-192.2%
VISK ↗	2025-12-31	—	—	—

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

CLNN ↗

Clene Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

RLAY ↗

Relay Therapeutics, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

TPL ↗

Texas Pacific Land Corp

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

NUVB ↗

Nuvation Bio Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

DSGN ↗

Design Therapeutics, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

OZ ↗

Belpointe PREP, LLC

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

LYEL ↗

Lyell Immunopharma, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

ADEA ↗

Adeia Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

RPRX ↗

Royalty Pharma plc

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

HRMY ↗

Harmony Biosciences Holdings, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

RYM ↗

RYTHM, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

GTBIF ↗

Green Thumb Industries Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →